BIIO (Bionovate Technologies) LT-Debt-to-Total-Asset: 0.00 (As of Sep. 2021)


What is Bionovate Technologies LT-Debt-to-Total-Asset?

Bionovate Technologies BIIO LT-Debt-to-Total-Asset is 0.00 as of Sep. 2021.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bionovate Technologies's long-term debt to total assests ratio for the quarter that ended in Sep. 2021 was 0.00.

Bionovate Technologies's long-term debt to total assets ratio stayed the same from Sep. 2020 (0.00) to Sep. 2021 (0.00).

Bionovate Technologies  (OTCPK:BIIO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Bionovate Technologies LT-Debt-to-Total-Asset Related Terms

Bionovate Technologies LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies LT-Debt-to-Total-Asset Chart

Bionovate Technologies Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bionovate Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bionovate Technologies LT-Debt-to-Total-Asset Calculation

Bionovate Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2021 is calculated as

LT Debt to Total Assets (A: Jun. 2021 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2021 )/Total Assets (A: Jun. 2021 )
=0/0
=

Bionovate Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2021 is calculated as

LT Debt to Total Assets (Q: Sep. 2021 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2021 )/Total Assets (Q: Sep. 2021 )
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Bionovate Technologies (BIIO) has a LT-Debt-to-Total-Asset of 0.00 as of Sep. 2021. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bionovate Technologies and its competitors.
Is Bionovate Technologies' LT-Debt-to-Total-Asset too high?
Bionovate Technologies' current LT-Debt-to-Total-Asset is 0.00.
How does Bionovate Technologies' LT-Debt-to-Total-Asset compare to ABT and MDT?
Bionovate Technologies' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Bionovate Technologies and its competitors. Bionovate Technologies's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionovate Technologies stock overvalued right now?
Bionovate Technologies (BIIO) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current LT-Debt-to-Total-Asset is 0.00 as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Address 950 W Bannock Street, Boise, ID, USA, 83702
Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.